Browse > Article
http://dx.doi.org/10.3345/kjp.2009.52.4.476

Polymorphisms of tumor necrosis factor-alpha promotor gene in Kawasaki disease and relation to the risk of coronary artery lesion  

Kim, Se-hwa (Department of Pediatrics, College of Medicine, Konyang University)
Yun, Jang-won (Department of Pediatrics, College of Medicine, Konyang University)
Lee, Young-hyuk (Department of Pediatrics, College of Medicine, Konyang University)
Cheon, Eun-jung (Department of Pediatrics, College of Medicine, Konyang University)
Publication Information
Clinical and Experimental Pediatrics / v.52, no.4, 2009 , pp. 476-480 More about this Journal
Abstract
Purpose : The purpose of this study was to investigate the polymorphisms of the TNF-alpha promotor gene, its susceptibility to Kawasaki disease (KD) and to assess whether the TNF-alpha promotor gene polymorphism was related the risk of coronary artery lesions (CALs). Methods : From January 2003 to January 2007, 51 children (30 boys and 21 girls) with KD and 48 children forming an age-matched control group were studied. DNA from the peripheral blood of all the children was sampled, and the DNA polymorphisms of the 5' flanking regions of the TNF-alpha promoter gene at position -308 [guanine (G) to adenine (A)] were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Then, the relationship between KD and the TNF-alpha promotor gene polymorphisms was evaluated. Results : The A allele frequency of the -308 site of the TNF-alpha promotor gene was 17.6% (9/51) for children with KD and 6.8% (3/48) for the control group children, but this result was not statistically significant. Twenty-four patients experienced CALs within 60 days after the onset of symptoms. KD children with TNF-alpha -308 A allele had lower frequencies of CALs (12.5% versus 22.2%, P>0.05). Conclusion : The DNA polymorphism of the -308 site TNF-alpha gene was not associated with susceptibility to KD and a risk of CALs. Multicenter, large-scale randomized controlled trials are needed for further study.
Keywords
Mucocutaneous lymph node syndrome; Coronary arteries; TNF-alpha polymorphism;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Oishi T, Fujieda M, Shiraishi T, Ono M, Inoue K, Takahashi A, et al. Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm. Circ J 2008;72:850-2   DOI   ScienceOn
2 Kim HR, Lee MK, Park AJ. The -308 and -238 Polymorphisms of the TNF-alpha promoter gene in type 2 diabetes mellitus. Korean J Lab Med 2006;26:58-63   DOI   PUBMED   ScienceOn
3 Chang RK. Epidemiologic characteristics of children hospitalized for Kawasaki disease in California. Pediatr Infect Dis J 2002;21:1150-5   DOI   PUBMED   ScienceOn
4 Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Storoupe C, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 2001;49:686-90   DOI   ScienceOn
5 Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 2003;187:326-9   DOI   ScienceOn
6 Komatsu H, Fujisawa T. Kawasaki disease and infection. Nippon Rinsho 2008;66:278-82   PUBMED
7 Abe J. Immunological aspects of Kawasaki disease. Nippon Rinsho 2008;66:267-71   PUBMED
8 Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003;44:1021-6   PUBMED   ScienceOn
9 Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129-34   DOI   ScienceOn
10 Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-8   DOI   ScienceOn
11 Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol Med 2001; 7:507-12   DOI   ScienceOn
12 Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-8   DOI   PUBMED   ScienceOn
13 Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9   DOI   ScienceOn
14 Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. The correlation between Kawasaki disease and polymorphisms of tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi 2003;41:598-602   PUBMED
15 Hui-Yuen JS, Duong TT, Yeung RS. TNF-alpha is neces sary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006 May 15;176:6294-301
16 Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, et al. Kawasaki disease in families. Pediatrics 1989;84:666-9   PUBMED   ScienceOn
17 Curtis N, Levin M. Kawasaki disease thirty years on. Curr Opin Pediatr 1998;10:24-33   DOI   ScienceOn
18 Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353   PUBMED
19 Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80   PUBMED   ScienceOn
20 Belay ED, Holman RC, Clarke MJ, Destefano F, Shahriari A, Davis RL, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J 2000;19:828-32   DOI   ScienceOn
21 Rowley AH, Shulman ST. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29   DOI   ScienceOn